Picture courtesy uk.news.yahoo.com
New Delhi: The central government’s Subject Expert Committee (SEC) is likely to meet on Wednesday on drugmaker Dr. Reddy’s application seeking emergency use authorisation for the Sputnik V vaccine in India. If the SEC gives a nod, Sputnik V will be India’s third vaccine after Covaxin and Covishield, News18 reported.
Dr. Reddy’s has partnered with the Sputnik V vaccine to run clinical trials in India. It had submitted the immunogenicity data after a meeting that was held on February 24.
Dr Reddy’s has partnered with Russia Direct Investment Fund (RDIF) to bring the Sputnik V vaccine to India. The Russian vaccine has shown an efficacy of 91.6 %.
Bargarh: Hrusikesh Bhoi, popular for his iconic role of Kansa in Bargarh’s Dhanu Jatra, has…
New Delhi: Canadian Prime Minister Justine Trudeau took to X to mark the sixth anniversary…
New Delhi: Israel on Thursday killed Hamas chief Yahya Sinwar in a Gaza operation. In…
New Delhi/Bhubaneswar: Three IAS officers, including Reghu G of Odisha cadre, have been shifted to…
Kolkata: A massive fire broke out at Sealdah ESI Hospital here on Friday morning. According…
New Delhi: The Enforcement Directorate Guwahati questioned actor Tamannaah Bhatia on Thursday in connection with…
Bhubaneswar: Days after the road rage incident involving an Army officer and his fiancee, a…
Mumbai: The Mumbai Traffic Police have received a threatening message via WhatsApp, demanding Rs 5…